Antibody Engineering 2016 Interview: Kerry Chester, UCL Cancer Institute & Janine Schuurman, Genmab

At Antibody Engineering & Therapeutics 2016 in San Diego, CA, we sat down with Kerry Chester, Ph.D., Professor of Molecular Medicine at UCL Cancer Institute, and Janine Schuurman, Ph.D., Vice President, Research at Genmab. Dr. Chester and Dr. Schuurman were co-chairs of the "Engineering Antibodies for T-Cell Therapy: CAR-T and Beyond" session at the event. Dr. Schuurman also presented "Antigen- and Fc-Dependent IgG Hexamer Formation: from Biology to Platform to Product" at the event.